Advertisement

HIV and Aging in Mainland China: Implications for Control and Prevention Research

  • Na HeEmail author
  • Yingying Ding
  • Jing Li
  • Shiying Yuan
  • Lulu Xu
  • Shijie Qiao
  • Xiaohui Xu
  • Bowen Zhu
  • Ruizi Shi
  • John P. Barile
  • Frank Y. WongEmail author
The Global Epidemic (SH Vermund, Section Editor)
  • 23 Downloads
Part of the following topical collections:
  1. Topical Collection on The Global Epidemic

Abstract

Purpose of Review

The last 15 years have witnessed a dramatic change in HIV-related epidemiology amidst improvements in treatment and care in China. With proper treatment, HIV is now considered a chronic disease. As a consequence, many people living with HIV (PLWH) now present age-related comorbidities. We reviewed 13 topical issues concerning the epidemiology of aging with HIV in mainland China.

Results

Many of aging-related issues associated with the biological and physical aspects of living with HIV addressed in mainland China are consistent with the global literature. Greater prevalence of age-related comorbidities among PLWH was observed. Beyond biological mechanisms associated with HIV infection and traditional risk factors, other factors play a vital role in the aging process among PLWH.

Summary

A stronger focus on screening, prevention, and management of non-HIV co-morbidities among PLWH is now warranted. Macro-social factors need to be integrated into next generation of clinical and/or behavioral HIV research to inform disease progression and management as well as prevention.

Keywords

Aging HIV Age-related diseases Risk factors China 

Notes

Funding Information

This research was supported by grants from the National Natural Science Foundation of China (81773485, 81872671, 81803291) and the China National Science and Technology Major Projects on Infectious Diseases (2018ZX10721102-004) and partially supported by Shanghai Municipal Health and Family Planning Commission (GWTD2015S05).

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Harman D. Aging: prospects for further increases in the functional life span. Age. 1994;17:119–46.CrossRefGoogle Scholar
  2. 2.
    Harman D. Aging: overview. Ann N Y Acad Sci. 2001;928:1–21.PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    Pathai S, Bajillan H, Landay AL, High KP. Is HIV a model of accelerated or accentuated aging? J Gerontol A Biol Sci Med Sci. 2014;69(7):833–42.PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    Althoff KN, Smit M, Reiss P, Justice AC. HIV and ageing: improving quantity and quality of life. Curr Opin HIV AIDS. 2016;11(5):527–36.PubMedPubMedCentralCrossRefGoogle Scholar
  5. 5.
    Zhang F, Dou Z, Ma Y, Zhang Y, Zhao Y, Zhao D, et al. Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study. Lancet Infect Dis. 2011;11(7):516–24.CrossRefGoogle Scholar
  6. 6.
    Dou Z, Zhang F, Zhao Y, Jin C, Zhao D, Gan X, et al. Progress on China’s national free antiretroviral therapy strategy in 2002–2014 [article in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi. 2015;36(12):1345–50.Google Scholar
  7. 7.
    Chen M, Dou Z, Wang L, Wu Y, Zhao D, Gan X, et al. Gender differences in outcomes of antiretroviral treatment among HIV-infected patients in China: a retrospective cohort study, 2010–2015. J Acquir Immune Defic Syndr. 2017;76(3):281–8.CrossRefGoogle Scholar
  8. 8.
    Wang C, Guo Q, Han Z, Chen D. Awareness rate of HIV/AIDS core knowledge among the elderly: a meta-analysis. Chin J AIDS & STD. 2019;2:148–52.Google Scholar
  9. 9.
    •• Ding Y, Lin H, Liu X, Wong FY, Sun YV, Marconi VC, et al. Higher prevalence of frailty among a sample of Chinese HIV-infected middle-aged and older adults is associated with neurocognitive impairment and depressive symptoms. J Infect Dis. 2017;215(5):687–69 This is the first study to report a higher prevalence of prefrailty and frailty among PLWH compared with similar but uninfected individuals in China and further indicate such association is partly explained by neurocognitive impairment and depressive symptoms. PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Cardiovascular health study collaborative research group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):146–56.CrossRefGoogle Scholar
  11. 11.
    Wang K, Lin H, Li L, Wu Q, Shen W, Liu X, et al. Low body mass index and efavirenz use are independently associated with self-reported fatigue in HIV-infected patients. AIDS Care. 2019;31(4):513–8.PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Chen WT, Shiu CS, Yang JP, Lee SY, Lee TS, Simoni JM, et al. Fatigue and sleep disturbance related to perceived stress in Chinese HIV-positive individuals: a mixed methods study. J AIDS Clin Res. 2013;4(6):15524.PubMedPubMedCentralGoogle Scholar
  13. 13.
    Lee KA, Hicks G, Nino-Murcia G. Validity and reliability of a scale to assess fatigue. Psychiatry Res. 1991;36(3):291–8.PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Guo F, Hsieh E, Lv W, Han Y, Xie J, Li Y, et al. Cardiovascular disease risk among Chinese antiretroviral-naïve adults with advanced HIV disease. BMC Infect Dis. 2017;17(1):287.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Cao Y, Gong M, Han Y, Xie J, Li X, Zhang L, et al. Prevalence and risk factors for chronic kidney disease among HIV-infected antiretroviral therapy-naïve patients in mainland China: a multicenter cross-sectional study. Nephrology (Carlton). 2013;18(4):307–12.CrossRefGoogle Scholar
  16. 16.
    Ding Y, Lin H, Liu X, Zhang Y, Wong FY, Sun YV, et al. Hypertension in HIV-infected adults compared with similar but uninfected adults in China: body mass index-dependent effects of nadir CD4 count. AIDS Res Hum Retrovir. 2017;33(11):1117–25.PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    •• Lin H, Ding Y, Ning C, Qiao X, Chen X, Chen X, et al. Age-specific associations between HIV Infection and carotid artery intima media thickness in China: a cross-sectional evaluation of baseline data from the CHART Cohort. Lancet HIV. Published Online October 18, 2019.  https://doi.org/10.1016/S2352-3018(19)302 S2352-3018(19)30263–2. This is the first large-scale cross-sectional survey to demonstrate a higher prevalence of subclinical atherosclerosis among PLWH compared with age and sex frequency-matched HIV-negative individuals in China, and such differences are more obvious at younger ages.
  18. 18.
    Shen Y, Wang Z, Liu L, Zhang R, Zheng Y, Lu H. Prevalence of hyperglycemia among adults with newly diagnosed HIV/AIDS in China. BMC Infect Dis. 2013;13:79.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Ye RH, Li J, Yao ST, Wang JB, Cao DD, Zhang YD, et al. Prevalence and related factors on diabetes among HIV/AIDS receiving antiretroviral therapy in Dehong Dai and Jingpo Autonomous Prefecture. Zhonghua Liu Xing Bing Xue Za Zhi. 2019;40:654μ9.Google Scholar
  20. 20.
    Cheng W, Wu Y, Dou Z, Ma Y, Sun L, Li Z, et al. The prevalence and relevant factors of hyperglycemia in AIDS patients receiving antiretroviral therapy in a single center. Zhonghua Nei Ke Za Zhi. 2014;53(6):446–9.PubMedGoogle Scholar
  21. 21.
    Zhang C, Chow FC, Han Y, Xie J, Qiu Z, Guo F, et al. Multicenter cohort study of diabetes mellitus and impaired fasting glucose in HIV-infected patients in China. J Acquir Immune Defic Syndr. 2015;68(3):298–303.PubMedCrossRefGoogle Scholar
  22. 22.
    Kooij KW, Vogt L, Wit FWNM, van der Valk M, van Zoest RA, Goorhuis A, et al. Higher prevalence and faster progression of chronic kidney disease in human immunodeficiency virus-infected middle-aged individuals compared with human immunodeficiency virus-uninfected controls. J Infect Dis. 2017;216(6):622–31.PubMedCrossRefGoogle Scholar
  23. 23.
    Ding Y, Duan S, Ye R, Yao S, Cao D, Yang Y, et al. Effects of aging, baseline renal function and stage of HIV infection on post‐treatment changes in renal function among HIV ‐infected patients: a retrospective cohort study. HIV Med. 2019;20(8):591–600.PubMedCrossRefGoogle Scholar
  24. 24.
    Cohen SD, Kopp JB, Kimmel PL. Kidney diseases associated with human immunodeficiency virus infection. N Engl J Med. 2017;377(24):2363–74.PubMedCrossRefGoogle Scholar
  25. 25.
    Schouten J, Wit FW, Stolte IG, Kootstra NA, van der Valk M, Geerlings SE, et al. Cross-sectional comparison of the prevalence of age-associated co-morbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. Clin Infect Dis. 2014;59(12):1787–97.PubMedCrossRefGoogle Scholar
  26. 26.
    Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA. 2014;311(24):2518–31.PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Pu L, Liu J, Luo Y, Zeng H, Guo H, Hao J, et al. Acute kidney injury in Chinese HIV-infected patients: a retrospective analysis from the intensive care unit. AIDS Patient Care STDs. 2018;32(10):381–9.PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    Li Y, Xie J, Han Y, Wang H, Lv W, Guo F, et al. Combination antiretroviral therapy is associated with reduction in liver fibrosis scores in HIV-1-infected subjects. Medicine (Baltimore). 2016;95(2):e2660.CrossRefGoogle Scholar
  29. 29.
    Ding Y, Duan S, Ye R, Yang Y, Yao S, Wang J, et al. More improvement than progression of liver fibrosis following antiretroviral therapy in a longitudinal cohort of HIV-infected patients with or without HBV and HCV co-infections. J Viral Hepat. 2017;24(5):412–20.PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Heaton RK, Cysique LA, Jin H, Shi C, Yu X, Letendre S, et al. Neurobehavioral effects of HIV infection among former plasma donors in rural China. J Neuro-Oncol. 2008;14(6):536–49.Google Scholar
  31. 31.
    Cysique LA, Letendre SL, Ake C, Jin H, Franklin DR, HIV Neurobehavioral Research Center group, et al. Incidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in China. AIDS. 2010;24(7):983–90.PubMedPubMedCentralCrossRefGoogle Scholar
  32. 32.
    Zhao T, Wei B, Long J, Tang X, Zhou M, Dang C. Cognitive disorders in HIV-infected and AIDS patients in Guangxi. China J Neurovirol. 2015;21(1):32–42.PubMedCrossRefPubMedCentralGoogle Scholar
  33. 33.
    Zhang Y, Qiao L, Ding W, Wei F, Zhao Q, Wang X, et al. An initial screening for HIV-associated neurocognitive disorders of HIV-1 infected patients in China. J Neuro-Oncol. 2012;18(2):120–6.Google Scholar
  34. 34.
    Ding Y, Lin H, Shen W, Wu Q, Gao M, He N. Interaction effects between HIV and aging on selective neurocognitive impairment. J NeuroImmune Pharmacol. 2017;12(4):661–9.PubMedCrossRefPubMedCentralGoogle Scholar
  35. 35.
    • Qiao X, Lin H, Chen X, Ning C, Wang K, Shen W, et al. Sex differences in neurocognitive screening among adults living with HIV in China. J Neurovirol. 2019;25(3):363–71 This study in China demonstrates that PLWH perform worse on cognitive measures compared with HIV-negative individuals, and sex difference is observed in HIV+ group only. PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Zhang YX, Gui XE, Zhong YH, Rong YP, Yan YJ. Cancer in cohort of HIV-infected population: prevalence and clinical characteristics. J Cancer Res Clin Oncol. 2011;137:609–14.PubMedCrossRefPubMedCentralGoogle Scholar
  37. 37.
    Yang J, Su S, Zhao H, Wang D, Wang J, Zhang F, et al. Prevalence and mortality of cancer among HIV-infected patients in Beijing. China BMC Infect Dis. 2016;16:82.PubMedCrossRefPubMedCentralGoogle Scholar
  38. 38.
    Jin ZY, Liu X, Ding YY, Zhang ZF, He N. Cancer risk factors among people living with HIV/AIDS in China: a systematic review and meta-analysis. Sci Rep. 2017;7:4890.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Shiels MS, Engels EA. Evolving epidemiology of HIV-associated malignancies. Curr Opin HIV AIDS. 2017;12(1):6–11.PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    • Franzetti M, Ricci E, Bonfanti P. The pattern of non-AIDS-defining cancers in the HIV population: epidemiology, risk factors and prognosis. A review Curr HIV Res. 2019;17:1–12 This study suggests that elevated insomnia and depressive symptoms may partly explain the correlation between HIV serostatus and shorter LTL. PubMedCrossRefPubMedCentralGoogle Scholar
  41. 41.
    Ding Y, Lin H, Zhou S, Wang K, Li L, Zhang Y, et al. Stronger association between insomnia symptoms and shorter telomere length in old HIV-positive patients compared with uninfected individuals. Aging Dis. 2018;9(6):1010–9.PubMedPubMedCentralCrossRefGoogle Scholar
  42. 42.
    Ren J, Zhao M, Liu B, Wu Q, Hao Y, Jiao M, et al. Factors associated with sleep quality in HIV. J Assoc Nurses AIDS Care. 2018;29(6):924–31.PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Huang X, Li H, Meyers K, Xia W, Meng Z, Li C, et al. Burden of sleep disturbances and associated risk factors: a cross-sectional survey among HIV-infected persons on antiretroviral therapy across China. Sci Rep. 2017;7:3657.PubMedPubMedCentralCrossRefGoogle Scholar
  44. 44.
    Ning C, Lin H, Chen X, Qiao X, Xu X, Xu X, et al. Cross-sectional comparison of various sleep disturbances among sex- and age-matched HIV-infected versus HIV-uninfected individuals in China. Sleep Med. 2020;65:18–25.CrossRefGoogle Scholar
  45. 45.
    Shan S, Shi Y, Ye R, Yang Y, Yang S, Tang R, et al. A cross-sectional survey of food intake frequency and dietary pattern among HIV/AIDS patients receiving antiretroviral therapy in Dehong prefecture, Yunnan province. Chin J AIDS & STD. 2017;23:116–9.Google Scholar
  46. 46.
    Liu Y, Lv Q, Gao J, Long L, Duan Z, Liang H, et al. Coinfection with HIV-1 alleviates iron accumulation in patients with chronic hepatitis C virus infection. PLoS One. 2014;9:e98039.PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Ji G, Qi R, Wang H, Feng C, Leng J. A “planting and eating soybean” project for people living with HIV/AIDS in rural Anhui-a pilot study in China. AIDS Care. 2010;22:126–32.PubMedCrossRefPubMedCentralGoogle Scholar
  48. 48.
    Zhou W, Ma R, Sharma M, Zhao Y. Nutritional attitudes of homosexual people living with human immunodeficiency virus (HIV) in Chongqing, Southwest China: a cross-sectional study. Int Q Community Health Educ 2013-2014; 34:87–100.PubMedCrossRefPubMedCentralGoogle Scholar
  49. 49.
    Ipp H, Zemlin A. The paradox of the immune response in HIV infection: when inflammation becomes harmful. Clin Chim Acta. 2013;416:96–9.PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Nou E, Lo J, Grinspoon SK. Inflammation, immune activation, and cardiovascular disease in HIV. AIDS. 2016;30(10):1495–509.PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Hileman CO, Funderburg NT. Inflammation, immune activation, and antiretroviral therapy in HIV. Curr HIV/AIDS Rep. 2017;14(3):93–100.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Sun J, Su J, Xie Y, Yin M, Huang Y, Xu L, et al. Plasma IL-6/IL-10 ratio and IL-8, LDH, and HBDH level predict the severity and the risk of death in AIDS patients with pneumocystis pneumonia. J Immunol Res. 2016;2016:1583951.PubMedPubMedCentralCrossRefGoogle Scholar
  53. 53.
    Zhao D, Ding Y, Lin H, Chen X, Shen W, Gao M, et al. Mitochondrial haplogroups N9 and G are associated with metabolic syndrome among human immunodeficiency virus-infected patients in China. AIDS Res Hum Retrovir. 2019;35(6):536–43.PubMedCrossRefPubMedCentralGoogle Scholar
  54. 54.
    Simoni JM, Safren SA, Manhart LE, Lyda K, Grossman CI, Rao D, et al. Challenges in addressing depression in HIV research: assessment, cultural context, and methods. AIDS Behav. 2011;15(2):376–88.PubMedPubMedCentralCrossRefGoogle Scholar
  55. 55.
    Li L, Ji G, Liang LJ, Lin C, Hsieh J, Lan CW, et al. Efficacy of a multilevel intervention on the mental health of people living with HIV and their family members in rural China. Health Psychol. 2017;36(9):863–71.PubMedPubMedCentralCrossRefGoogle Scholar
  56. 56.
    Diaz RM, Ayala G, Bein E, Henne J, Marin BV. The impact of homophobia, poverty, and racism on the mental health of gay and bisexual Latino men: findings from 3 US cities. Am J Public Health. 2001;91(6):927–32.PubMedPubMedCentralCrossRefGoogle Scholar
  57. 57.
    Brown JR, O’Connor GT. Coronary heart disease and prevention in the United States. N Engl J Med. 2010;362(23):2150–3.CrossRefGoogle Scholar
  58. 58.
    Galea S, Ahern J, Nandi A, Tracy M, Beard J, Vlahov D. Urban neighborhood poverty and the incidence of depression in a population-based cohort study. Ann Epidemiol. 2007;17(3):171–9.PubMedPubMedCentralCrossRefGoogle Scholar
  59. 59.
    Singer M. Introduction to syndemics: a critical systems approach to public and community health. John Wiley & Sons; 2009.Google Scholar
  60. 60.
    Stall R, Mills TC, Williamson J, Hart T, Greenwood G, Paul J, et al. Association of co-occurring psychosocial health problems and increased vulnerability to HIV/AIDS among urban men who have sex with men. Am J Public Health. 2003;93(6):939–42.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Na He
    • 1
    • 2
    Email author
  • Yingying Ding
    • 1
  • Jing Li
    • 1
  • Shiying Yuan
    • 1
  • Lulu Xu
    • 1
  • Shijie Qiao
    • 1
  • Xiaohui Xu
    • 1
  • Bowen Zhu
    • 1
  • Ruizi Shi
    • 1
  • John P. Barile
    • 3
  • Frank Y. Wong
    • 1
    • 3
    • 4
    Email author
  1. 1.Department of Epidemiology, School of Public Health, The Key Laboratory of Public Health Safety of Ministry of EducationFudan UniversityShanghaiChina
  2. 2.Key Laboratory of Health Technology Assessment of Ministry of HealthFudan UniversityShanghaiChina
  3. 3.Department of PsychologyUniversity of Hawai’i at MānoaHonoluluUSA
  4. 4.Center for Indigenous Nursing Research for Health EquityFlorida State UniversityTallahasseeUSA

Personalised recommendations